Literature DB >> 31230960

Generation of functional hepatocyte-like cells from human bone marrow mesenchymal stem cells by overexpression of transcription factor HNF4α and FOXA2.

Pei-Yi Xie1, Xiao-Jun Hu2, Ruo-Mi Guo3, Xiao-Chun Meng4, Peng-Fei Pang2, Zhi-Yang Zhou4, Dan Li2, Hong Shan5.   

Abstract

BACKGROUND: Our previous study showed that overexpression of hepatocyte nuclear factor 4α (HNF4α) could directly promote mesenchymal stem cells (MSCs) to differentiate into hepatocyte-like cells. However, the efficiency of hepatic differentiation remains low. The purpose of our study was to establish an MSC cell line that overexpressed HNF4α and FOXA2 genes to obtain an increased hepatic differentiation efficiency and hepatocyte-like cells with more mature hepatocyte functions.
METHODS: Successful establishment of high-level HNF4α and FOXA2 co-overexpression in human induced hepatocyte-like cells (hiHep cells) was verified by flow cytometry, immunofluorescence and RT-PCR. Measurements of albumin (ALB), urea, glucose, indocyanine green (ICG) uptake and release, cytochrome P450 (CYP) activity and gene expression were used to analyze mature hepatic functions of hiHep cells.
RESULTS: hiHep cells efficiently express HNF4α and FOXA2 genes and proteins, exhibit typical epithelial morphology and acquire mature hepatocyte-like cell functions, including ALB secretion, urea production, ICG uptake and release, and glycogen storage. hiHep cells can be activated by CYP inducers. The percentage of both ALB and α-1-antitrypsin (AAT)-positive cells was approximately 72.6%. The expression levels of hepatocyte-specific genes (ALB, AAT, and CYP1A1) and liver drug transport-related genes (ABCB1, ABCG2, and SLC22A18) in hiHep cells were significantly higher than those in MSCs-Vector cells. The hiHep cells did not form tumors after subcutaneous xenograft in BALB/c nude mice after 2 months.
CONCLUSION: This study provides an accessible, feasible and efficient strategy to generate hiHep cells from MSCs.
Copyright © 2019 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hepatic differentiation; Hepatocyte nuclear factor; Mesenchymal stem cells

Mesh:

Substances:

Year:  2019        PMID: 31230960     DOI: 10.1016/j.hbpd.2019.03.013

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  6 in total

1.  Indocyanine Green Uptake and Periodic Acid-Schiff Staining Method for Function Detection of Liver Cells are Affected by Different Cell Confluence.

Authors:  Li Tao; Shu-Yu Fang; Li Zhao; Tong-Chuan He; Yun He; Yang Bi
Journal:  Cytotechnology       Date:  2021-01-30       Impact factor: 2.058

Review 2.  Liver regeneration and alcoholic liver disease.

Authors:  Yi Lv; Kwok Fai So; Jia Xiao
Journal:  Ann Transl Med       Date:  2020-04

Review 3.  Pre-treatments enhance the therapeutic effects of mesenchymal stem cells in liver diseases.

Authors:  Chenxia Hu; Zhongwen Wu; Lanjuan Li
Journal:  J Cell Mol Med       Date:  2019-11-06       Impact factor: 5.310

4.  Long noncoding RNA SNHG1 silencing accelerates hepatocyte-like cell differentiation of bone marrow-derived mesenchymal stem cells to alleviate cirrhosis via the microRNA-15a/SMURF1/UVRAG axis.

Authors:  Jia Sun; Xuedong Sun; Sean Hu; Maoqiang Wang; Na Ma; Junhui Chen; Feng Duan
Journal:  Cell Death Discov       Date:  2022-02-22

Review 5.  Genetic modification by overexpression of target gene in mesenchymal stromal cell for treating liver diseases.

Authors:  Chenxia Hu; Lingfei Zhao; Lanjuan Li
Journal:  J Mol Med (Berl)       Date:  2021-01-02       Impact factor: 4.599

Review 6.  Regulated differentiation of stem cells into an artificial 3D liver as a transplantable source.

Authors:  Feng Chen; Hua Wang; Jia Xiao
Journal:  Clin Mol Hepatol       Date:  2020-02-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.